default author photo

Awadhesh Kumar Singh

GD Hospital & Diabetes Institute - Diabetes & Endocrinology

India

SCHOLARLY PAPERS

1

DOWNLOADS

27

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Efficacy and Safety of Fixed-Dose Dapagliflozin-Pioglitazone in Indian Adults with Type 2 Diabetes: Results from the Randomized Phase 3 PRO-1 Trial

Number of pages: 28 Posted: 15 Oct 2025
Awadhesh Kumar Singh, Krishna Seshadri, Ambika G. Unnikrishnan, Jothydev Kesavadev, Sanjay Kalra, Shashank R Joshi, Kaushik Pandit, Rakesh Kumar Sahay, Vijay Panikar, Ambrish Mithal, Smriti Gadia and Thamburaj Anthuvan
GD Hospital & Diabetes Institute - Diabetes & Endocrinology, Apollo Hospital, JSS Academy of Higher Education and Research, Independent, Bharti Hospital, Lilavati Hospital and Research Centre - Department of Diabetology and Endocrinology, Institute of Postgraduate Medical Education & Research (IPGMER), Osmania Medical College, Lilavati Hospital and Research Centre - Department of Diabetology and Endocrinology, Medanta-The Medicity - Division of Endocrinology and Diabetes, USV Pvt. Ltd and S.B.Patil Institute of Management
Downloads 27 (1,372,601)

Abstract:

Loading...

Type 2 diabetes mellitu, fixed-dose combination, dapagliflozin, pioglitazone, India, Pro 1 Study, MASLD, NAFLD